Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Fonti

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|August 12, 2018
Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding IntegrinsMarcello Monti, Viviana De Rosa, Francesca Iommelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2014
Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomographyFrancesca Iommelli, Viviana De Rosa, Sara Gargiulo, et al.
Clinical Nuclear Medicine|March 15, 2013
Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumorsSerena De Luca, Rosa Fonti, Giovannella Palmieri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2022
Heterogeneity of SSTR2 Expression Assessed by <sup>68</sup>Ga-DOTATOC PET/CT Using Coefficient of Variation in Patients with Neuroendocrine TumorsRosa Fonti, Mariarosaria Panico, Sara Pellegrino, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2008
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myelomaRosa Fonti, Barbara Salvatore, Mario Quarantelli, et al.
Endocrine|March 25, 2018
The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept studyAntongiulio Faggiano, Roberta Modica, Rosa Severino, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|April 27, 2018
2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosisBarbara Salvatore, Rosa Fonti, Amalia De Renzo, et al.
Cancers|April 30, 2021
A Reversible Shift of Driver Dependence from EGFR to Notch1 in Non-Small Cell Lung Cancer as a Cause of Resistance to Tyrosine Kinase InhibitorsFrancesca Iommelli, Viviana De Rosa, Cristina Terlizzi, et al.
Endocrine|August 6, 2015
Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1)Secondo Lastoria, Francesca Marciello, Antongiulio Faggiano, et al.
British Journal of Haematology|July 12, 2022
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II studyMarco Picardi, Claudia Giordano, Novella Pugliese, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|August 12, 2018
Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding IntegrinsMarcello Monti, Viviana De Rosa, Francesca Iommelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2014
Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomographyFrancesca Iommelli, Viviana De Rosa, Sara Gargiulo, et al.
Clinical Nuclear Medicine|March 15, 2013
Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumorsSerena De Luca, Rosa Fonti, Giovannella Palmieri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2022
Heterogeneity of SSTR2 Expression Assessed by <sup>68</sup>Ga-DOTATOC PET/CT Using Coefficient of Variation in Patients with Neuroendocrine TumorsRosa Fonti, Mariarosaria Panico, Sara Pellegrino, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2008
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myelomaRosa Fonti, Barbara Salvatore, Mario Quarantelli, et al.
Endocrine|March 25, 2018
The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept studyAntongiulio Faggiano, Roberta Modica, Rosa Severino, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|April 27, 2018
2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosisBarbara Salvatore, Rosa Fonti, Amalia De Renzo, et al.
Cancers|April 30, 2021
A Reversible Shift of Driver Dependence from EGFR to Notch1 in Non-Small Cell Lung Cancer as a Cause of Resistance to Tyrosine Kinase InhibitorsFrancesca Iommelli, Viviana De Rosa, Cristina Terlizzi, et al.
Endocrine|August 6, 2015
Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1)Secondo Lastoria, Francesca Marciello, Antongiulio Faggiano, et al.
British Journal of Haematology|July 12, 2022
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II studyMarco Picardi, Claudia Giordano, Novella Pugliese, et al.
Pageof 6